PROMBot-HSM-AF: protocol for a feasibility study of a chatbot-based platform to collect patient-reported outcomes after atrial fibrillation ablation - Report - MDSpire
Clinical Report: Feasibility Study Protocol for PROMBot-HSM-AF
Overview
This study aims to evaluate the feasibility, usability, and acceptability of a chatbot-driven platform for gathering patient-reported outcomes following atrial fibrillation ablation. The pilot trial will assess chatbot engagement and retention among patients compared to standard care.
Background
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting a significant portion of the population and associated with serious cardiovascular risks. Catheter ablation is increasingly used as a first-line treatment, yet many patients require follow-up assessments due to complications or recurrences. Remote patient monitoring, particularly through chatbots, may enhance follow-up care.
Data Highlights
No numerical data available in the source material.
Key Findings
The study will randomize 76 patients to either chatbot-supported follow-up or standard care.
Feasibility will be assessed through recruitment rates, retention, and chatbot engagement.
Usability and acceptability will be evaluated using the System Usability Scale (SUS) and semi-structured interviews.
Preliminary evidence will emerge from this pilot trial.
The study addresses a gap in evidence for using chatbots in post-procedural settings.
Clinical Implications
The findings from this pilot trial will provide data on chatbot-driven monitoring in post-ablation care.
Conclusion
This feasibility study will contribute to understanding chatbot applications in post-ablation care.
by Sérgio Laranjo, Pedro Silva Cunha, Federico Guede-Fernández, Eduarda Oliosi, Rita Contins, Pedro Dias, Catarina Silva, Ana Clara Félix, Mário Martins Oliveira, Ana Rita Londral
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
Advanced heart failure does not always present as a single defining event. Referring physicians may instead notice a pattern of worsening symptoms, recurrent hospitalizations or increasing difficulty maintaining a patient’s clinical stability.
